Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and symptomless dysphagia.
Arai
T
T
Yasuda
Y
Y
Takaya
T
T
Toshima
S
S
Kashiki
Y
Y
Yoshimii
N
N
Fujiwara
H
H
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007093:Imidazoles / Q000627:therapeutic use; D048289:Imidazolidines; D019808:Losartan / Q000627:therapeutic use; D008297:Male; D011015:Pneumonia, Aspiration / Q000517:prevention & control; D020521:Stroke / Q000150:complications / Q000188:drug therapy*; D013373:Substance P / Q000097:blood
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007093:Imidazoles; D048289:Imidazolidines; D013373:Substance P; C065166:imidapril; D019808:Losartan